Maynard Um
-
-
-
-
-
-
-
BD and EMS launch semaglutide in Brazil using BD's Vystra pen platform
-
-
-
-
-
-
-
Becton Dickinson (BDX) Tops Q2 EPS by 12c ; Offers Guidance
-
-
-
-
-
-
-
BD receives CE mark for liver disease stent graft in Europe
-
-
-
-
-
-
-
BD launches $1.6 billion tender offers to buy back outstanding debt
-
-
-
-
-
-
-
Becton Dickinson (BDX) Tops Q1 EPS by 10c ; Offers Guidance
-
-
-
-
-
-
-
BD and Ypsomed develop 5.5ml syringe for large-volume biologics
-
-
-
-
-
-
-
KeyBanc on Life Sciences Tools & Services: 'We Highlight Our Favored 2026 "Tools" Stocks'
-
453,334 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

